Investec Investment Banking & Securities has hired Jens Lindqvist and Brough Ransom to strengthen its healthcare team.
Lindqvist joins Investec from investment bank N+1 Singer, where he spent more than ten years as a senior research analyst evaluating public and private equity in the UK life sciences sector, as well as originating mandates and helping to raise funds.
Ransom also joins from N+1 Singer where he worked as senior sales executive for almost six and a half years. He was responsible for promoting healthcare stocks to investors and raising money for IPOs and secondary fundraisings. Ransom has 22 years experience in the sector at a variety of institutions including Merrill Lynch, ING and Nomura.
Both men will work alongside healthcare analyst Andrew Whitney as well as Daniel Adams and Gary Clarence, who lead Investec’s healthcare advisory offering.
Harold Hutchinson, head of research at Investec, said: ‘We see a particular opportunity for further growth in biotech and pharmaceuticals, building on our existing success across the healthcare sector. We believe that these hires – together with our top-ranked generalist sales and trading platforms – give us the strongest offering in the sector.’